$NOVN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NOVEN PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in NOVEN PHARMACEUTICALS INC. Get notifications about new insider transactions in NOVEN PHARMACEUTICALS INC for free.

Page:   1 2 3 4 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Venditti AnthonyVP - Marketing and ...Option ExerciseD11.0939,037432,9200
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Venditti AnthonyVP - Marketing and ...Option ExerciseD10.6979,139845,9960
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...Option ExerciseD11.0966,921742,1540
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...Option ExerciseD13.9362,500870,6250
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Lippman JoelVP and Chief Medica ...Option ExerciseD11.0933,460371,0710
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Lippman JoelVP and Chief Medica ...Option ExerciseD10.8678,520852,7270
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...DINH STEVEN MVP & Chief Scientif ...Option ExerciseD11.0939,037432,9200
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...DINH STEVEN MVP & Chief Scientif ...Option ExerciseD11.8453,107628,7870
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Gilbert Richard P.Vice President - Op ...Option ExerciseD11.0966,921742,1540
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Gilbert Richard P.Vice President - Op ...Option ExerciseD14.5429,806433,3790
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Gilbert Richard P.Vice President - Op ...Option ExerciseD22.8319,908454,5000
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Gilbert Richard P.Vice President - Op ...Option ExerciseD13.6823,191317,2530
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Gilbert Richard P.Vice President - Op ...Option ExerciseD16.3530,000490,5000
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseD11.0971,701795,1640
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseD14.5452,161758,4210
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseD22.8323,527537,1210
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseD13.6830,864422,2200
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseD22.6050,0001,130,0000
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseD10.4524,000250,8000
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseD13.1119,099250,3880
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...SellD16.501,83530,27801.8 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorOption ExerciseD17.417,500130,5750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorOption ExerciseD18.737,500140,4750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorOption ExerciseD11.302,50028,2500
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorOption ExerciseD9.745,00048,7000
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorOption ExerciseD21.155,000105,7500
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorOption ExerciseD19.6612,500245,7500
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorSellD16.5011,309186,599011.3 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOOption ExerciseD9.4762,712593,8830
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOOption ExerciseD11.09188,4712,090,1430
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOOption ExerciseD9.10311,5292,834,9140
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOSellU16.50183,3333,024,9950183.3 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Savage Robert G.DirectorOption ExerciseD17.417,500130,5750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Savage Robert G.DirectorOption ExerciseD18.737,500140,4750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Savage Robert G.DirectorOption ExerciseD18.9015,000283,5000
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Savage Robert G.DirectorSellD16.509,120150,48009.1 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...Nader FrancoisDirectorSellD16.5010,943180,560010.9 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorOption ExerciseD16.6744,297738,4310
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorSellD16.509,120150,48009.1 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorOption ExerciseD17.417,500130,5750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorOption ExerciseD22.5315,000337,9500
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorSellD16.509,120150,48009.1 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorOption ExerciseD17.417,500130,5750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorOption ExerciseD18.737,500140,4750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorOption ExerciseD18.9015,000283,5000
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorSellD16.509,120150,48009.1 K to 0 (-100.00 %)
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...CLARKSON JOHN GDirectorOption ExerciseD17.417,500130,5750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...CLARKSON JOHN GDirectorOption ExerciseD18.737,500140,4750
Aug 27 2009NOVNNOVEN PHARMACEUTIC ...CLARKSON JOHN GDirectorSellD16.509,120150,48009.1 K to 0 (-100.00 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...SellU16.5025,000412,500025 K to 0 (-100.00 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...SellU16.5011,846195,4591,83513.7 K to 1.8 K (-86.59 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorSellU16.5035,082578,85311,30946.4 K to 11.3 K (-75.62 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOSellU16.50111,6671,842,506183,333295 K to 183.3 K (-37.85 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...Savage Robert G.DirectorSellU16.5023,659390,3749,12032.8 K to 9.1 K (-72.18 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorSellU16.5047,159778,1249,12056.3 K to 9.1 K (-83.80 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...Nader FrancoisDirectorSellU16.503,64860,19210,94314.6 K to 10.9 K (-25.00 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorSellU16.5032,817541,4819,12041.9 K to 9.1 K (-78.25 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...CLARKSON JOHN GDirectorSellU16.5023,259383,7749,12032.4 K to 9.1 K (-71.83 %)
Aug 21 2009NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorSellU16.5033,659555,3749,12042.8 K to 9.1 K (-78.68 %)
May 27 2009NOVNNOVEN PHARMACEUTIC ...Savage Robert G.DirectorGrantA0.0012,160032,77920.6 K to 32.8 K (+58.97 %)
May 27 2009NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorGrantA0.0012,160056,27944.1 K to 56.3 K (+27.56 %)
May 27 2009NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorGrantA0.0012,160041,93729.8 K to 41.9 K (+40.84 %)
May 27 2009NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorGrantA0.0012,160042,77930.6 K to 42.8 K (+39.71 %)
May 27 2009NOVNNOVEN PHARMACEUTIC ...CLARKSON JOHN GDirectorGrantA0.0012,160032,70720.5 K to 32.7 K (+59.18 %)
May 27 2009NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorGrantA0.0015,078046,39131.3 K to 46.4 K (+48.15 %)
May 27 2009NOVNNOVEN PHARMACEUTIC ...Nader FrancoisDirectorGrantA0.0014,591014,5910 to 14.6 K
Mar 12 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.0011,324101,9162,486,4442.5 M to 2.5 M (-0.45 %)
Mar 06 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.341,10010,2742,497,7682.5 M to 2.5 M (-0.04 %)
Mar 06 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.02232,0002,092,6402,498,8682.7 M to 2.5 M (-8.50 %)
Mar 04 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.655295,1052,730,8682.7 M to 2.7 M (-0.02 %)
Feb 23 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.655,39852,0912,731,3972.7 M to 2.7 M (-0.20 %)
Feb 23 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.657,00067,5502,736,7952.7 M to 2.7 M (-0.26 %)
Feb 19 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.6510,00096,5002,743,7952.8 M to 2.7 M (-0.36 %)
Feb 19 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.6817,000164,5602,753,7952.8 M to 2.8 M (-0.61 %)
Feb 17 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.9121,561213,6702,770,7952.8 M to 2.8 M (-0.77 %)
Feb 17 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS10.0114,140141,5412,792,3562.8 M to 2.8 M (-0.50 %)
Feb 06 2009NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOOption ExerciseA9.4762,712593,88362,712
Feb 02 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS9.9825,000249,5002,806,4962.8 M to 2.8 M (-0.88 %)
Feb 02 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS10.1025,000252,5002,831,4962.9 M to 2.8 M (-0.88 %)
Jan 21 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.00100,0001,100,0002,956,4963.1 M to 3 M (-3.27 %)
Jan 29 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS10.5550,000527,5002,856,4962.9 M to 2.9 M (-1.72 %)
Jan 29 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS10.3250,000516,0002,906,4963 M to 2.9 M (-1.69 %)
Jan 13 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.007,98987,8793,056,4963.1 M to 3.1 M (-0.26 %)
Jan 09 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.0929,039322,0433,064,4853.1 M to 3.1 M (-0.94 %)
Jan 09 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.1650,000558,0003,093,5243.1 M to 3.1 M (-1.59 %)
Jan 07 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.0550,000552,5003,143,5243.2 M to 3.1 M (-1.57 %)
Jan 07 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.0166,290729,8533,193,5243.3 M to 3.2 M (-2.03 %)
Jan 05 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.0234,621381,5233,259,8143.3 M to 3.3 M (-1.05 %)
Jan 05 2009NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.0074,409818,4993,294,4353.4 M to 3.3 M (-2.21 %)
Dec 31 2008NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.00677373,368,8443.4 M to 3.4 M (0.00 %)
Dec 29 2008NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.001,25513,8053,368,9113.4 M to 3.4 M (-0.04 %)
Dec 29 2008NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.009,503104,5333,370,1663.4 M to 3.4 M (-0.28 %)
Dec 29 2008NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS11.0038,735426,0853,379,6693.4 M to 3.4 M (-1.13 %)
Nov 25 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.452,50023,62525,00022.5 K to 25 K (+11.11 %)
Nov 25 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.414,28140,28422,50018.2 K to 22.5 K (+23.50 %)
Nov 25 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.293,21929,90518,21915 K to 18.2 K (+21.46 %)
Nov 24 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOOption ExerciseA11.09188,4712,090,143188,471
Nov 20 2008NOVNNOVEN PHARMACEUTIC ...Lippman JoelVP and Chief Medica ...Option ExerciseA11.0933,461371,08233,461
Nov 20 2008NOVNNOVEN PHARMACEUTIC ...Venditti AnthonyVP - Marketing and ...Option ExerciseA11.0939,038432,93139,038
Nov 20 2008NOVNNOVEN PHARMACEUTIC ...DINH STEVEN MVP & Chief Scientif ...Option ExerciseA11.0939,038432,93139,038
Nov 20 2008NOVNNOVEN PHARMACEUTIC ...Gilbert Richard P.Vice President - Op ...Option ExerciseA11.0966,922742,16566,922
Nov 20 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...Option ExerciseA11.0966,922742,16566,922
Nov 20 2008NOVNNOVEN PHARMACEUTIC ...EISENBERG JEFFREY FExecutive Vice Pres ...Option ExerciseA11.0971,702795,17571,702
Oct 31 2008NOVNNOVEN PHARMACEUTIC ...OSS CAPITAL MANAGEMENT10% OwnerSellS10.656,28666,9463,418,4043.4 M to 3.4 M (-0.18 %)
Jul 15 2008NOVNNOVEN PHARMACEUTIC ...Lippman JoelVP and Chief Medica ...Option ExerciseA10.8678,520852,72778,520
Sep 02 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP12.3919,059236,141295,000275.9 K to 295 K (+6.91 %)
Sep 02 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP12.385276,524275,941275.4 K to 275.9 K (+0.19 %)
Sep 02 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP12.371151,423275,414275.3 K to 275.4 K (+0.04 %)
Sep 02 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP12.362993,696275,299275 K to 275.3 K (+0.11 %)
Jul 02 2008NOVNNOVEN PHARMACEUTIC ...Venditti AnthonyVP - Marketing and ...Option ExerciseA10.6979,139845,99679,139
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.362002,27244,11943.9 K to 44.1 K (+0.46 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.351001,13543,91943.8 K to 43.9 K (+0.23 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.341261,42943,81943.7 K to 43.8 K (+0.29 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.333513,97743,69343.3 K to 43.7 K (+0.81 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.324004,52843,34242.9 K to 43.3 K (+0.93 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.311,17413,27842,94241.8 K to 42.9 K (+2.81 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.302,90832,86041,76838.9 K to 41.8 K (+7.48 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.291,44916,35938,86037.4 K to 38.9 K (+3.87 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.287,81888,18737,41129.6 K to 37.4 K (+26.42 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.275,69664,19429,59323.9 K to 29.6 K (+23.84 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.262,35226,48423,89721.5 K to 23.9 K (+10.92 %)
Jun 16 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorBuyP11.252,42627,29321,54519.1 K to 21.5 K (+12.69 %)
Jun 09 2008NOVNNOVEN PHARMACEUTIC ...Savage Robert G.DirectorGrantA0.0010,121020,61910.5 K to 20.6 K (+96.41 %)
Jun 09 2008NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorGrantA0.0010,121031,31321.2 K to 31.3 K (+47.76 %)
Jun 09 2008NOVNNOVEN PHARMACEUTIC ...SATOW PHILLIP MDirectorGrantA0.0010,121019,1199 K to 19.1 K (+112.48 %)
Jun 09 2008NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorGrantA0.0010,121029,77719.7 K to 29.8 K (+51.49 %)
Jun 09 2008NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorGrantA0.0010,121030,61920.5 K to 30.6 K (+49.38 %)
Jun 06 2008NOVNNOVEN PHARMACEUTIC ...DINH STEVEN MVP & Chief Scientif ...Option ExerciseA11.8453,107628,78753,107
Jun 09 2008NOVNNOVEN PHARMACEUTIC ...CLARKSON JOHN GDirectorGrantA0.0010,121020,54710.4 K to 20.5 K (+97.07 %)
Jun 09 2008NOVNNOVEN PHARMACEUTIC ...BRAGINSKY SIDNEYDirectorGrantA0.0010,121027,31317.2 K to 27.3 K (+58.87 %)
Jun 05 2008NOVNNOVEN PHARMACEUTIC ...Yetter Wayne P.DirectorBuyP11.7810,000117,80021,19211.2 K to 21.2 K (+89.35 %)
May 15 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP9.8210,00098,200275,000265 K to 275 K (+3.77 %)
May 15 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP9.7610,00097,600265,000255 K to 265 K (+3.92 %)
May 15 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP9.862,88428,436255,000252.1 K to 255 K (+1.14 %)
May 15 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP9.799168,968252,116251.2 K to 252.1 K (+0.36 %)
May 15 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP9.731,0009,730251,200250.2 K to 251.2 K (+0.40 %)
May 15 2008NOVNNOVEN PHARMACEUTIC ...Brandt Peter C.President and CEOBuyP9.692001,938250,200250 K to 250.2 K (+0.08 %)
Jun 03 2008NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorBuyP11.421,03011,76319,65618.6 K to 19.7 K (+5.53 %)
Jun 03 2008NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorBuyP11.415005,70518,62618.1 K to 18.6 K (+2.76 %)
Jun 03 2008NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorBuyP11.402,87032,71818,12615.3 K to 18.1 K (+18.81 %)
May 19 2008NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorBuyP10.908,10088,29020,49812.4 K to 20.5 K (+65.33 %)
May 19 2008NOVNNOVEN PHARMACEUTIC ...DENKHAUS DONALD ADirectorBuyP10.891,90020,69112,39810.5 K to 12.4 K (+18.10 %)
May 15 2008NOVNNOVEN PHARMACEUTIC ...GRANADILLO PEDRO PDirectorBuyP9.895,00049,45015,25610.3 K to 15.3 K (+48.75 %)
May 14 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.784443015,00015 K to 15 K (+0.29 %)
May 14 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.791,95619,14914,95613 K to 15 K (+15.05 %)
May 14 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.804,50044,10013,0008.5 K to 13 K (+52.94 %)
May 14 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.813,10030,4118,5005.4 K to 8.5 K (+57.41 %)
May 14 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.841009845,4005.3 K to 5.4 K (+1.89 %)
May 14 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.861009865,3005.2 K to 5.3 K (+1.92 %)
May 14 2008NOVNNOVEN PHARMACEUTIC ...PRICE MICHAEL DENNISVP and Chief Financ ...BuyP9.871,0009,8705,2004.2 K to 5.2 K (+23.81 %)

Page:   1 2 3 4 4 next >